Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
A conserved rod domain phosphotyrosine that is targeted by the phosphatase PTP1B promotes keratin 8 protein insolubility and filament organization.
[alexander disease]
Post-translational
modifications
are
important
functional
determinants
for
intermediate
filament
(
IF
)
proteins
.
Phosphorylation
of
IF
proteins
regulates
filament
organization
,
solubility
,
and
cell-protective
functions
.
Most
known
IF
protein
phosphorylation
sites
are
serines
localized
in
the
variable
"
head
"
and
"
tail
"
domain
regions
.
By
contrast
,
little
is
known
about
site-
specific
tyrosine
phosphorylation
or
its
implications
on
IF
protein
function
.
We
used
available
proteomic
data
from
large
scale
studies
to
narrow
down
potential
phospho-tyrosine
sites
on
the
simple
epithelial
IF
protein
keratin
8
(
K
8
)
.
Validation
of
the
predicted
sites
using
a
pan-phosphotyrosine
and
a
site-
specific
antibody
,
which
we
generated
,
revealed
that
the
highly
conserved
Tyr-
267
in
the
K
8
"
rod
"
domain
was
basally
phosphorylated
.
The
charge
at
this
site
was
critically
important
,
as
demonstrated
by
altered
filament
organization
of
site-directed
mutants
,
Y
267
F
and
Y
267
D
,
the
latter
exhibiting
significantly
diminished
solubility
.
Pharmacological
inhibition
of
the
protein-tyrosine
phosphatase
PTP
1
B
increased
K
8
Tyr-
267
phosphorylation
,
decreased
solubility
,
and
increased
K
8
filament
bundling
,
whereas
PTP
1
B
overexpression
had
the
opposite
effects
.
Furthermore
,
there
was
significant
co
-localization
between
K
8
and
a
"
substrate-trapping
"
mutant
of
PTP
1
B
(
D
181
A
)
.
Because
K
8
Tyr-
267
is
conserved
in
many
IFs
(
QYE
motif
)
,
we
tested
the
effect
of
the
paralogous
Tyr
in
glial
fibrillary
acidic
protein
(
GFAP
)
,
which
is
mutated
in
Alexander
disease
(
Y
242
D
)
.
Similar
to
K
8
,
Y
242
D
GFAP
exhibited
highly
irregular
filament
organization
and
diminished
solubility
.
Our
results
implicate
the
rod
domain
QYE
motif
tyrosine
as
an
important
determinant
of
IF
assembly
and
solubility
properties
that
can
be
dynamically
modulated
by
phosphorylation
.
Diseases
Validation
Diseases presenting
"highly irregular filament organization"
symptom
alexander disease
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom